Trial Profile
A Clinical Trial to Investigate the Diabetes Vaccine Diamyd in Combination with Gamma Aminobutyric Acid (GABA/Diamyd)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2018
Price :
$35
*
At a glance
- Drugs GAD65 vaccine (Diamyd) (Primary) ; Gamma amino butyric acid (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 18 Feb 2016 New trial record